purine deoxyribonucleosides degradation
Pathways in the purine deoxyribonucleosides degradation SuperPath
| # | Name | Source | Genes |
|---|---|---|---|
| 1 | purine deoxyribonucleosides degradation | PubChem | |
| 2 | purine ribonucleosides degradation | PubChem | |
| 3 | purine ribonucleosides degradation to ribose-1-phosphate | PubChem | |
| 4 | purine deoxyribonucleosides degradation II | PubChem | |
| 5 | Nucleotide catabolism defects | Reactome | |
| 6 | Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | Reactome | |
| 7 | Defective ADA disrupts (deoxy)adenosine deamination | Reactome |
Disorders associated with purine deoxyribonucleosides degradation SuperPath
according to GeneCards Suite gene sharing
| # | Disorder | Type | Genes | Score |
|---|---|---|---|---|
| 1 | Purine-pyrimidine metabolic disorder | Direct | ||
| 2 | Purine nucleoside phosphorylase deficiency | Direct | ||
| 3 | Adenosine deaminase deficiency | Direct | ||
| 4 | Severe combined immunodeficiency | Enrichment | ADA, PNP | 5.24 |
| 5 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency | Enrichment | ADA | 3.35 |
| 6 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative | Enrichment | ADA | 3.13 |
| 7 | Omenn syndrome | Enrichment | ADA | 2.83 |